These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 24819618)
1. Simultaneous assessment of rotavirus-specific memory B cells and serological memory after B cell depletion therapy with rituximab. Herrera D; Rojas OL; Duarte-Rey C; Mantilla RD; Angel J; Franco MA PLoS One; 2014; 9(5):e97087. PubMed ID: 24819618 [TBL] [Abstract][Full Text] [Related]
2. Characterization of rotavirus specific B cells and their relation with serological memory. Rojas OL; Narváez CF; Greenberg HB; Angel J; Franco MA Virology; 2008 Oct; 380(2):234-42. PubMed ID: 18789807 [TBL] [Abstract][Full Text] [Related]
3. The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment. Cambridge G; Perry HC; Nogueira L; Serre G; Parsons HM; De La Torre I; Dickson MC; Leandro MJ; Edwards JC J Autoimmun; 2014 May; 50():67-76. PubMed ID: 24365380 [TBL] [Abstract][Full Text] [Related]
4. Human rotavirus-specific IgM Memory B cells have differential cloning efficiencies and switch capacities and play a role in antiviral immunity in vivo. Narváez CF; Feng N; Vásquez C; Sen A; Angel J; Greenberg HB; Franco MA J Virol; 2012 Oct; 86(19):10829-40. PubMed ID: 22855480 [TBL] [Abstract][Full Text] [Related]
5. Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity. Maurer MA; Rakocevic G; Leung CS; Quast I; Lukačišin M; Goebels N; Münz C; Wardemann H; Dalakas M; Lünemann JD J Clin Invest; 2012 Apr; 122(4):1393-402. PubMed ID: 22426210 [TBL] [Abstract][Full Text] [Related]
6. Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura. Becerra E; Scully MA; Leandro MJ; Heelas EO; Westwood JP; De La Torre I; Cambridge G Clin Exp Immunol; 2015 Mar; 179(3):414-25. PubMed ID: 25339550 [TBL] [Abstract][Full Text] [Related]
7. Characterising the Phenotypic Diversity of Antigen-Specific Memory B Cells Before and After Vaccination. Tjiam MC; Fernandez S; French MA Front Immunol; 2021; 12():738123. PubMed ID: 34650561 [TBL] [Abstract][Full Text] [Related]
8. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens. Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777 [TBL] [Abstract][Full Text] [Related]
9. Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis. Marino M; Basile U; Spagni G; Napodano C; Iorio R; Gulli F; Todi L; Provenzano C; Bartoccioni E; Evoli A Front Immunol; 2020; 11():613. PubMed ID: 32431692 [TBL] [Abstract][Full Text] [Related]
10. Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides. Venhoff N; Effelsberg NM; Salzer U; Warnatz K; Peter HH; Lebrecht D; Schlesier M; Voll RE; Thiel J PLoS One; 2012; 7(5):e37626. PubMed ID: 22629432 [TBL] [Abstract][Full Text] [Related]
11. Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis. Rehnberg M; Amu S; Tarkowski A; Bokarewa MI; Brisslert M Arthritis Res Ther; 2009; 11(4):R123. PubMed ID: 19686595 [TBL] [Abstract][Full Text] [Related]
12. Baseline serum immunoglobulin levels in patients with rheumatoid arthritis: relationships with clinical parameters and with B-cell dynamics following rituximab. de la Torre I; Leandro MJ; Edwards JC; Cambridge G Clin Exp Rheumatol; 2012; 30(4):554-60. PubMed ID: 22510323 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of circulating intestinally committed memory B cells in children vaccinated with attenuated human rotavirus vaccine. Rojas OL; Caicedo L; Guzmán C; Rodríguez LS; Castañeda J; Uribe L; Andrade Y; Pinzón R; Narváez CF; Lozano JM; De Vos B; Franco MA; Angel J Viral Immunol; 2007; 20(2):300-11. PubMed ID: 17603846 [TBL] [Abstract][Full Text] [Related]
14. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. Sellam J; Rouanet S; Hendel-Chavez H; Abbed K; Sibilia J; Tebib J; Le Loët X; Combe B; Dougados M; Mariette X; Taoufik Y Arthritis Rheum; 2011 Dec; 63(12):3692-701. PubMed ID: 22127692 [TBL] [Abstract][Full Text] [Related]
15. CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis. Sellam J; Rouanet S; Hendel-Chavez H; Miceli-Richard C; Combe B; Sibilia J; Le Loët X; Tebib J; Jourdan R; Dougados M; Taoufik Y; Mariette X Arthritis Rheum; 2013 Sep; 65(9):2253-61. PubMed ID: 23740460 [TBL] [Abstract][Full Text] [Related]
16. Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones. Tian C; Luskin GK; Dischert KM; Higginbotham JN; Shepherd BE; Crowe JE J Immunol; 2008 Mar; 180(5):3279-88. PubMed ID: 18292552 [TBL] [Abstract][Full Text] [Related]
17. Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients. van Dam LS; Oskam JM; Kamerling SWA; Arends EJ; Bredewold OW; Berkowska MA; van Dongen JJM; Rabelink TJ; van Kooten C; Teng YKO Front Immunol; 2020; 11():566732. PubMed ID: 33384685 [TBL] [Abstract][Full Text] [Related]
18. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. DiLillo DJ; Hamaguchi Y; Ueda Y; Yang K; Uchida J; Haas KM; Kelsoe G; Tedder TF J Immunol; 2008 Jan; 180(1):361-71. PubMed ID: 18097037 [TBL] [Abstract][Full Text] [Related]
19. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients. Westra J; van Assen S; Wilting KR; Land J; Horst G; de Haan A; Bijl M Clin Exp Immunol; 2014 Oct; 178(1):40-7. PubMed ID: 24889761 [TBL] [Abstract][Full Text] [Related]
20. Chronic signs of memory B cell activation in patients with Behçet's disease are partially restored by anti-tumour necrosis factor treatment. van der Houwen TB; van Hagen PM; Timmermans WM; Bartol SJ; Lam KH; Kappen JH; van Zelm MC; van Laar JA Rheumatology (Oxford); 2017 Jan; 56(1):134-144. PubMed ID: 27744360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]